| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |